Trinity Biotech PLC 6-K, filed Nov 4, 2022
Trinity Biotech PLC (TRIB)
6-K
2022-11-04
For: 2022-11-04
View Original
Added on
July 07, 2026
About this 6-K
Trinity Biotech PLC filed this 6-K on November 4, 2022.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
F O R M 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2022
TRINITY BIOTECH PLC
(Name of Registrant)
IDA Business Park
Bray, Co. Wicklow, Ireland
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form
20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7):
Indicate by check mark whether by furnishing the information contained in this Form, the registrant
is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ☐ No ☒
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule
12g3-2(b): 82-
EXPLANATORY NOTE
On November 03, 2022, Trinity Biotech plc. issued a press release announcing its second quarter 2022 financial results. A copy of the
press release is furnished herewith as Exhibit 99.1.
EXHIBIT INDEX
|
Exhibit
|
Description
|
|
|
99.1
|
Trinity Biotech announces Quarter 2 2022 Financial Results and Preliminary Q3 Revenue Guidance
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.
|
TRINITY BIOTECH PLC
|
|||
|
Trinity Biotech plc
|
|||
|
(Registrant)
|
|||
|
By:
|
/s/ John Gillard
|
||
|
John Gillard
|
|||
|
Chief Financial Officer
|
|||
Date: November 04, 2022